Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9975886 Potassium channel modulators

Patent 9975886 was granted and assigned to Cadent Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cadent Therapeutics

Current Assignee

Cadent Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

99758860

Patent Inventor Names

Kelly Foster0

Thomas Amos Jacobsen0

Dipak Vasantrao Amrutkar0

Gregg F. Keaney0

Janus Schreiber Larsen0

Karin Sandager Nielsen0

Martin R. Jefson0

Date of Patent

May 22, 2018

Patent Application Number

158779100

Date Filed

January 23, 2018

Patent Citations Received

‌

US Patent 11993586 Crystalline forms of potassium channel modulators

Patent Primary Examiner

‌

Jeffrey H Murray

Patent abstract

Provided are compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9975886 Potassium channel modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API